Building on the success of GLOW1 and with all patients on a 6-month dosing interval, Zenkuda (tarcocimab tedromer) demonstrated superiority to sham with 62.5% of Zenkuda-treated patients achieving ...
CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies ...
First regulatory clearance in Latin America marks a strategic milestone for regional market expansion- World's first ...
Following back-to-back MLB Postseason appearances in 2024 and 2025, the Detroit Tigers will welcome fans back to Comerica ...
X Financial (NYSE:XYF) said it deliberately slowed activity in the fourth quarter of 2025 to remain aligned with evolving ...
Preliminary Q4 revenue range -- $18.1 million-$30 million, driven by a single complex multiparty nonmonetary transaction for ...
Students and others are asking universities, including Harvard and Ohio State, to take down the names of high-profile donors ...
Wrap Technologies, Inc. (NASDAQ: WRAP) (“Wrap” or the “Company”), a global leader in non-lethal response, today announced ...
For more than 30 years, the US Postal Service has sent people who need to change their addresses to MyMove. Experts say the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results